tradmap

DLB Financials Dolby Laboratories, Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 3.0% per year over the past 5 years.
  • Net income has grown slower than revenue (2.0% vs 3.0% per year).
  • Operating margin has been roughly flat, at 19.6% in the latest year.
  • Free cash flow has grown 9.4% per year over the past 5 years.

Shareholder returns

  • Dividends have been paid for 8 consecutive years, consuming 49.6% of earnings and 29.0% of free cash flow.
  • The dividend has grown 7.4% per year over the past 5 years.
Revenue & net income
$0 $675M $1B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 45% 90% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 9% 19% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $218M $436M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $613M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$611M -$69M $472M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $1.3B $255M 88.1% 19.6% 9.7% 7.9% $436M — $702M
2024 $1.3B $262M 89.0% 20.3% 10.6% 8.4% $297M — $482M
2023 $1.3B $201M 88.3% 16.6% 8.5% 6.7% $337M — $745M
2022 $1.3B $184M 88.7% 16.5% 8.2% 6.8% $271M — $620M
2021 $1.3B $310M 89.9% 26.9% 11.9% 10.0% $393M — $1.2B
2020 $1.2B $231M 87.4% 18.8% 9.5% 7.9% $278M — $1.1B
2019 $1.2B $255M 87.0% 20.7% 11.1% 9.0% $231M — $797M
2018 $1.1B $42M 87.9% 17.4% 1.8% 1.5% $279M — $918M
2017 — $206M — — 9.7% 8.1% $278M — $634M
2016 — $186M — — 9.4% 8.0% $259M — $520M
2015 — $181M — — 10.0% 8.5% $152M — $532M
2014 — $206M — — 12.1% 10.4% $286M — $568M
2013 — $189M — — 12.8% 10.9% $250M — $454M
2012 — $264M — — 15.4% 13.5% $223M — $493M
2011 — $309M — — 18.6% 16.4% $356M — $552M

Valuation over time

How the market has priced DLB against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 22.5 45.1 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 3.3 6.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 1.3 2.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is DLB growing its revenue and profit?

Over the past 5 years, Dolby Laboratories, Inc.'s revenue has grown 3.0% per year, and net income grown 2.0% per year. These are computed facts, not advice.

How much debt does DLB have?

As of FY2025, Dolby Laboratories, Inc. reported — of total debt against $702M of cash.

What is DLB's profit margin?

In FY2025, gross margin was 88.1%, operating margin 19.6%, and net margin 18.9%.

What is DLB's P/E ratio?

Dolby Laboratories, Inc.'s P/E (TTM) is 26.25 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the DLB stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 23.3× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.